A transcriptional enhancer has been identified in the first intron of the mouse a2 (type I) collagen gene in a region between +418 and + 1524 base pairs from the transcriptional start site. The enhancer functions both when it is located 5' and 3' to the promoter that it activates and is independent of the orientation of the element. The enhancer stimulates both the homologous a2 type I [a2(I)J collagen promoter and the heterologous early simian virus 40 promoter. In transient expression experiments, enhancer-dependent transcription from the a2(I) Collagen promoter utilizes the same transcriptional start site as the one used in the endogenous C2(I) collagen gene. The enhancer activates transcription at a distance of at least 3 kilobase pairs from the transcriptional start site. The a2(I) collagen enhancer displays cell specificity, since it is functional in NIH 3T3 fibroblasts but completely inactive in a lymphoid cell line, in contrast to two immunoglobulin gene enhancers that show the opposite behavior. We find several areas of sequence homology with viral enhancers, particularly the enhancer of simian virus 40.
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Enhancer elements are cis-acting DNA sequences able to activate transcription from both homologous and heterologous promoters (for reviews, see refs. [1] [2] [3] . This stimulation is independent of the orientation of the element and occurs whether the enhancer is located 5' or 3' to the promoter. Enhancers are active at distances of several kilobases (kb) from the transcriptional start site. First described in the simian virus 40 (SV40) genome (4) (5) (6) (7) (8) , several enhancers or enhancer-like sequences were later reported in other viral genomes (1) (2) (3) . Subsequently, enhancer elements were also found in several cellular genes. The first cellular enhancer was identified in the heavy-chain immunoglobulin gene (9, 10) . Its peculiarity was its location in the first intron of the gene and its strict tissue specificity. Tissue specificity has also been observed for other cellular enhancers (1) (2) (3) . With the exception of the immunoglobulin and f-globin gene enhancers (11) (12) (13) , viral and cellular enhancers are in the vast majority of the cases located in a position 5 ' to their promoter.
Type I collagen represents a major component of the extracellular matrix and constitutes one of the most abundantly synthesized proteins in vertebrates. It is produced in a variety of tissues, but mainly in tendons, skin, and bones. Its synthesis is normally restricted to cells of the mesenchymal lineage, mainly fibroblasts and osteoblasts, and to a lesser degree chondroblasts and cells of smooth and striated muscle. Under normal conditions, cells of ectodermal or endodermal origin, as well as cells of the hematopoietic lineage, do not produce type I collagen. The synthesis of type I collagen is also developmentally regulated, since it appears in the mouse embryo around day 8-9 (14, 15) . Several collagen genes have been isolated. These genes are large and contain >50 exons (16) (17) (18) CAT activity is expressed as the ratio between the activity of the test plasmid and the basal level of activity of the plasmid containing the same promoter without enhancer element. Data represent averages of at least two independent transfection experiments.
in Fig. 5 ) was labeled at its 3' end using the Klenow fragment of DNA polymerase and [a32P]dCTP. The DNA sequence was analyzed using programs available in the NIH mainframe DEC-10 computer.
DNA Transfections, Chloramphenicol Acetyltransferase (CAT) Assays, and RNA Analysis. NIH 3T3 mouse fibroblasts were transfected essentially as described (24) using 10-cmdiameter dishes and 1 ml of Ca3(PO4)2-DNA precipitate, containing between 7 and 15 ,g of plasmid DNA. A lymphoid cell line, S194 (a kind gift of C. Queen, National Institutes of Health), was transfected with a modified DEAE-dextran protocol as described (25) . Equimolar amounts of each plasmid were used in all the experiments. Forty-eight hours after DNA transfection, the cells were harvested and analyzed either for CAT activity (26) , using equal amounts of protein from each extract, or for RNA analysis. CAT activity was determined by counting strips cut from the thin-layer chromatography plates that correspond to the acetylated forms of [14C]chloramphenicol identified by autoradiography. The data in the table represent the averages of at least two independent transfections. For the primer-extension experiment shown in Fig. 4 , total RNA from NIH 3T3 fibroblasts was extracted by the guanidine thiocyanate/ cesium chloride method (27) 60 hr after DNA transfection. Equal amounts of total RNAs were hybridized with an excess of a 5'-end-labeled CAT antisense synthetic oligonucleotide. The conditions for hybridization, reverse transcription, and electrophoretic analysis of the cDNA products were as described (20) . moter, without the SV40 enhancer, linked to the CAT gene. The Bgl II site in pA1OCAT2 is immediately 5' to the SV40 early promoter-CAT fusion (Fig. 1) . In transient expression experiments, the pA1OCAT2 vector exhibits a low level of CAT expression. Some fragments were also inserted in the BamHI site of pAZ1003, a vector in which a DNA segment of the mouse a2(I) collagen gene (-2000 to +54) containing the promoter of this gene is fused to the CAT gene. The BamHI site in pAZ1003 is --1.5 kbp 3' to the collagen promoter. Table 1 indicates the endpoints in the a2(I) collagen gene of each fragment that was tested for enhancer activity and summarizes the results of the transient expression assays performed with the various constructions. Fig. 2 and 3 show examples of representative CAT assays.
A 5-kbp fragment, spanning sequences from position +54 to approximately +5000, showed a clear enhancer activity with both the a2(I) collagen promoter (Fig. 2, pR23 ) and the SV40 early promoter (Fig. 2, pR22 ). This fragment contains =200 bp of the first exon followed by the first intron and the continuation of the gene in the 3' direction. The enhancing activity was seen when the fragment was cloned in the direct orientation in the pAZ1003 vector and in the opposite orientation in the pA1OCAT2 vector. However, the enhancing activity was lost when the orientation was inverted (Fig.  2, pR24 and pR21) . A possible simple explanation for this observation is that an enhancer element is present in the 5-kb insert but that it is closer to the 5' end of this fragment and that its activity is strongly reduced by increasing the distance between the enhancer and each of the two promoters that were used in the assays. Indeed, when fragments between +54 and +2500, (Table 1, pR25 and pR26) and between +2500 and +5000 (Table 1, pR27) were subcloned in pAlOCAT2, only the +54 to +2500 fragment showed enhancing activity. This time, the enhancing activity was observed when the fragment was cloned in one or the other orientation, even though the effect was somewhat higher in the opposite than in the direct orientation.
Enhancing activity was also observed when a smaller fragment was assayed removing 400 bp from the 3' end of the 2.5-kbp fragment ( Table 1 . In this and other experiments, CAT activities were measured after transfection of three types of plasmids: (i) the basal levels of activities of pA10CAT2 or pAZ1003; (ii) the levels of activities of the plasmids containing the a2(I) collagen intron segments; (iii) the levels of activities of constructions containing the SV40 enhancer-i.e., pSV2CAT or pAZ1009-as positive controls.
Plasmid pSV2CAT contains the full SV40 enhancer element immediately 5' to the early SV40 promoter (26) . Plasmid pAZ1009 is a pAZ1003 derivative in which a 135-bp fragment containing the SV40 enhancer was inserted 3' to the CAT gene (24) . located between +802 and +948. Alternatively, the enhancer might be divided in two distinct domains, one located between +54 and +9484 the other between +802 and +1800. Strong enhancement was also achieved with fragments spanning from +418 to + 1524 ( (Fig. 3, pR40, pR41 ). The slight difference between the two orientations observed in the experiment shown in Fig. 3 was not observed in other experiments.
Other experiments showed that the activity of the mouse a2(I) collagen promoter was not increased when a fragment of 15 kbp preceding the start of transcription was placed in the vector instead of the 2-kbp mouse collagen fragment in pAZ1003. Also, no increase of basal expression was detectable when a fragment from +134 to +748 was inserted in the BamHI site of pAZ1003 (see Table 1 , plasmids pR43 and pR44). The 1.1-kbp fragment from +418 to +1524 stimulates the formation of correctly initiated CAT transcripts from the a2(I) collagen promoter. This was shown by a primerextension experiment (Fig. 4) . Lane 2 shows the presence of a cONA doublet -z145 nucleotides long that corresponds to transcripts starting from the same place as previously identified as the transcriptional start sites in the endogenous mouse a2(I) collagen gene. This doublet is not detectable with RNA extracted from mock-transfected cells (lane 3).
DNA Sequence of the a2(I) Collagen Gene Enhancer Element. The sequence of the mouse a2(I) collagen gene, between +1 to + 1529 is shown in Fig. SB. This figure also shows the sequencing strategy used for determining the sequence of both DNA strands (Fig. 5A) .
Sequence analysis of the segment between +54 and + 1524 reveals several interesting features: (i) The sequence contains two enhancer "core" elements (GTGGTAAAG) as found in several viral enhancers (1, 2), one from +295 to +302, the other from + 1301 to + 1308. Both core sequences are outside a segment that has maximal enhancing activity (+418 to + 1040). where one of the two enhancer core elements is found. The areas of homology between the a2(I) collagen enhancer and the SV40 enhancer element fall outside a segment of the viral enhancer that is common with a sequence in the IgG K-chain enhancer. This sequence binds a nuclear factor found in cells of the B-lymphoid lineage (28) . Homologies were also found with other enhancer sequences, such as the enhancers of polyomavirus and of the long terminal repeat of Rous sarcoma virus.
No clear homologies were found between the sequence of the first intron of the mouse a2(I) collagen gene and the sequence ofthe first intron of the corresponding chicken gene (17) . However, several areas of homology were found between the sequence reported in Fig. 5 ulin gene enhancer (pKCAT K) or the heavy-chain immunopendent from the distance globulin gene enhancer (pKCAT H) driving the expression of promoter, since it is observ the K-chain promoter (29) . (iv) One plasmid containing the 5' to the SV40 early pron SV40 enhancer with its own promoter (pSV2CAT) and one collagen promoter. plasmid containing the SV40 enhancer with the a2(I) collagen
In our experiments, the promoter (pAZ1009). All 10 plasmids were transfected both when tested with the SV in NIH 3T3 fibroblasts and in cells of a lymphoid line (S194). tested with the a2(I) collage Fig. 6 shows that every construction that contains the a2(I) (20) . Thus, both the promoter and the enhancer ofthe a2(I) collagen gene contain sequences that confer tissue specificity to this gene, presumably restricting its expression Sw*to cells derived from mesenchymal cells. Cell-specific expression of the a2(I) collagen enhancer. Plasmids were transfected either in NIH 3T3 fibroblasts (A) or in the mouse lymphoid cell line S194 (B). In both plasmids pKCATK and pKCATH, the mouse K-chain immunoglobulin promoter drives the CAT gene; pKCATK contains a mouse K-chain immunoglobulin gene enhancer and pKCATH contains the mouse heavy-chain immunoglobulin gene enhancer. These two plasmids are described in detail the ref. 29 . the first exon maps at position +208, and the sequence between +54 and +1524 does not contain the 11-nucleotide sequence of the second exon, previously identified around position +2100 in the chicken a2(I) collagen genomic sequence (17) and also present in the human a2(I) collagen gene (F. Ramirez, personal communication).
The activity of the mouse a2(I) collagen gene enhancer was completely inhibited when a 5-kbp insert containing sequences between +54 and +5000 was cloned in the direct orientation 5' to the SV40 early promoter or in the opposite orientation 3' to the cognate promoter. In these constructions, the sequences needed for full enhancement (between nucleotides +418 and +1524) are 3.5-kbp away from the SV40 early promoter or 5 kbp from the a2(I) collagen promoter. This distance per se may render the enhancer inactive or, alternatively, sequences within this segment may interfere with the activity of the enhancer.
The a2(I) collagen enhancer is very active in NIH 3T3 fibroblasts but completely inactive in a lymphoid cell line, in contrast to the K-chain or heavy-chain immunoglobulin enhancer, which are inactive in fibroblasts but active in 
